Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVV1) vs. Competitors

9 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NVV1NovavaxEUR 7.18EUR 1.19B-17.3318.09%HoldUnlock the DE:NVV1 analyst price target with TipRanks PremiumDE:NVV1Unlock the DE:NVV1 top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.25$1.58B-7.4068.49%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumDE:NVV1 vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$8.00$831.45M-5.35-33.67%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumDE:NVV1 vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.03$3.60B-23.08206.39%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumDE:NVV1 vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.88$563.31M-3.55-48.35%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumDE:NVV1 vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NVV1Novavax7.181.4024.24%
VIRVir Biotechnology9.253.7568.18%
ORICOric Pharmaceuticals8.00-3.90-32.77%
ABCLAbCellera Biologics11.037.37201.37%
SANASana Biotechnology1.88-1.65-46.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts